MeiraGTx Holdings (MGTX) Other Non-Current Assets (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Other Non-Current Assets of $2.3 million for Q4 2025, up 12.59% on a YoY basis from $2.0 million in Q4 2024, and up 103.6% quarter-over-quarter from $1.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) Other Non-Current Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Other Non-Current Assets for 9 years, with the latest figure at $2.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 12.59% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 12.59% YoY), and the FY2025 full-year result was $2.3 million, up 12.59% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $2.3 million, up from $1.1 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.3 million in Q4 2025, with the low at $201000.0 in Q3 2021.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets tumbled 72.75% — and 2022, when it jumped 557.71%.
- MeiraGTx Holdings' Other Non-Current Assets stood at $783000.0 in 2021, then jumped by 79.05% to $1.4 million in 2022, then jumped by 36.73% to $1.9 million in 2023, then advanced by 4.8% to $2.0 million in 2024, then gained by 12.59% to $2.3 million in 2025.
- The last three Other Non-Current Assets figures came in at $2.3 million (Q4 2025), $1.1 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 753,000.00 |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 723,000.00 |
| Mar 31, 2022 | 772,000.00 |
| Dec 31, 2021 | 783,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Jun 30, 2021 | 1.20 Mn |
| Mar 31, 2021 | 812,000.00 |